300347 Stock Overview
Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 300347 from our risk checks.
Hangzhou Tigermed Consulting Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥59.11 |
52 Week High | CN¥94.20 |
52 Week Low | CN¥36.12 |
Beta | 0.71 |
1 Month Change | 13.59% |
3 Month Change | 53.41% |
1 Year Change | -33.84% |
3 Year Change | -61.18% |
5 Year Change | 43.70% |
Change since IPO | 214.08% |
Recent News & Updates
Recent updates
Shareholder Returns
300347 | CN Life Sciences | CN Market | |
---|---|---|---|
7D | 11.5% | 6.3% | 3.1% |
1Y | -33.8% | -36.1% | -13.1% |
Return vs Industry: 300347 exceeded the CN Life Sciences industry which returned -36.1% over the past year.
Return vs Market: 300347 underperformed the CN Market which returned -13.1% over the past year.
Price Volatility
300347 volatility | |
---|---|
300347 Average Weekly Movement | 9.5% |
Life Sciences Industry Average Movement | 9.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300347's share price has been volatile over the past 3 months.
Volatility Over Time: 300347's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 9,701 | Xiaochun Cao | www.tigermedgrp.com |
Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services.
Hangzhou Tigermed Consulting Co., Ltd Fundamentals Summary
300347 fundamental statistics | |
---|---|
Market cap | CN¥47.81b |
Earnings (TTM) | CN¥1.69b |
Revenue (TTM) | CN¥7.24b |
30.2x
P/E Ratio7.1x
P/S RatioIs 300347 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300347 income statement (TTM) | |
---|---|
Revenue | CN¥7.24b |
Cost of Revenue | CN¥4.48b |
Gross Profit | CN¥2.76b |
Other Expenses | CN¥1.07b |
Earnings | CN¥1.69b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.96 |
Gross Margin | 38.10% |
Net Profit Margin | 23.36% |
Debt/Equity Ratio | 11.1% |
How did 300347 perform over the long term?
See historical performance and comparison